2210
Immunotherapy, Anaphylaxis
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
195
Epit Prevents from the Induction of Anaphylaxis to Further Allergens: Role of Naive Tregs
Lucie Mondoulet, PhD Vincent Dioszeghy, PhD Emilie Puteaux Mélanie Ligouis Véronique Dhelft Camille Plaquet Christophe Dupont, MD PhD Pierre-Henri Benhamou, MD
197
Conjunctival Provocation Test in Daily Practice: Four Ocular Symptoms Vs Ocular Pruritus Score System
Carmen Rondon, MD PhD Paloma Campo, MD PhD Esther Barrionuevo, MD, PhD Ana Prieto del Prado, MD Gador Bogas, MD Arturo Ruiz, MD Maria Auxiliadora Guerrero Leticia Herrero Pedro A Galindo Diana Perez-Alzate, MD Miguel Blanca, MD, PhD
201
Intralymphatic Pollen-Specific Immunotherapy for Nasal Allergy: Clinical Efficacy and Effects on the Induction of Pollen- Specific Antibody
Tetsuya Terada Syuji Omura Yusuke Kikuoka Megumi Yoshida Manabu Suzuki Shinpei Ichihara Takahiro Ichihara Takaki Inui Ryo Kawata
202
Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period
Petra U. Zieglmayer, MD Hendrik Nolte, MD, PhD Harold S. Nelson, MD FAAAAI David I. Bernstein, MD FAAAAI Amarjot Kaur, PhD Ziliang Li, PhD Rene Zieglmayer Rene Schmutz, MD Patrick Lemell, PhD Friedrich Horak, MD
207
Fel d 1 Peptide Immunotherapy Ameliorates Both Cat and Ovalbumin Responses, in a Dual Allergen Murine Model of Allergic Airways Disease
Daniel M. Moldaver Mantej S. Bharhani Christopher D Rudulier, PhD Jennifer Wattie Mark D. Inman, MD PhD Mark Larché, PhD
208
Endometrial Anaphylaxis Due to Subcutaneous Immunotherapy (SCIT): A Case Series
Manideep Nandigam Frank J. Eidelman, MD FAAAAI Ves Dimov, MD
See more of: Abstracts